PL2768527T3 - Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1 - Google Patents

Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1

Info

Publication number: PL2768527T3
Authority: PL; Poland
Prior art keywords: diabetes; preventing; treating type; cbv; vaccine
Prior art date: 2011-10-18

Application number

PL12775490T

Other languages

English (en)

Inventor

Heikki Hyöty

Mikael Knip

Olli Laitinen

Outi Tolonen

Minna Pulkki

Sami Oikarinen

Hanna-Riikka Honkanen

Valérie Lecouturier

Jeffrey Almond

Malin Flodström-Tullberg

Original Assignee

Vactech Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-10-18

Filing date

2012-10-18

Publication date

2017-12-29

2012-10-18 Application filed by Vactech Oy filed Critical Vactech Oy

2017-12-29 Publication of PL2768527T3 publication Critical patent/PL2768527T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/106—Picornaviridae (F), e.g. hepatitis A virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Communicable Diseases (AREA)
Peptides Or Proteins (AREA)

PL12775490T 2011-10-18 2012-10-18 Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1 PL2768527T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP11306344.0A EP2583688A1 (en)	2011-10-18	2011-10-18	Multi-CBV vaccine for preventing or treating type 1 diabetes
EP12775490.1A EP2768527B1 (en)	2011-10-18	2012-10-18	Multi-cbv vaccine for preventing or treating type 1 diabetes
PCT/EP2012/070653 WO2013057191A1 (en)	2011-10-18	2012-10-18	Multi-cbv vaccine for preventing or treating type 1 diabetes

Publications (1)

Publication Number	Publication Date
PL2768527T3 true PL2768527T3 (pl)	2017-12-29

Family

ID=47049165

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12775490T PL2768527T3 (pl)	2011-10-18	2012-10-18	Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1

Country Status (6)

Country	Link
US (7)	US20140255425A1 (pl)
EP (2)	EP2583688A1 (pl)
DK (1)	DK2768527T3 (pl)
ES (1)	ES2643696T3 (pl)
PL (1)	PL2768527T3 (pl)
WO (1)	WO2013057191A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2583688A1 (en)	2011-10-18	2013-04-24	Sanofi Pasteur	Multi-CBV vaccine for preventing or treating type 1 diabetes
WO2023076856A1 (en) *	2021-10-25	2023-05-04	Provention Bio, Inc.	Coxsackievirus b compositions and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1187631B1 (en)	1999-06-24	2004-09-22	Heikki Hyöty	Prevention of type 1 diabetes and other non-polio enterovirus diseases
US20100047273A1 (en)	2007-05-07	2010-02-25	Rino Rappuoli	Coxsackie B virus and type 1 diabetes
DE102009034553A1 (de) *	2009-07-23	2011-01-27	Oerter, Detlef, Dr.	Impfstoff zur Prävention von akuter lymphoblastischer Leukämie bei Kindern
EP2583688A1 (en) *	2011-10-18	2013-04-24	Sanofi Pasteur	Multi-CBV vaccine for preventing or treating type 1 diabetes

2011
- 2011-10-18 EP EP11306344.0A patent/EP2583688A1/en not_active Withdrawn
2012
- 2012-10-18 ES ES12775490.1T patent/ES2643696T3/es active Active
- 2012-10-18 PL PL12775490T patent/PL2768527T3/pl unknown
- 2012-10-18 EP EP12775490.1A patent/EP2768527B1/en active Active
- 2012-10-18 WO PCT/EP2012/070653 patent/WO2013057191A1/en not_active Ceased
- 2012-10-18 US US14/352,585 patent/US20140255425A1/en not_active Abandoned
- 2012-10-18 DK DK12775490.1T patent/DK2768527T3/da active
2017
- 2017-03-22 US US15/465,854 patent/US10258685B2/en active Active
2019
- 2019-02-01 US US16/265,681 patent/US10780157B2/en active Active
- 2019-02-01 US US16/265,677 patent/US10675344B2/en active Active
2020
- 2020-08-17 US US16/995,439 patent/US11633468B2/en active Active
2021
- 2021-04-07 US US17/224,430 patent/US11911456B2/en active Active
2024
- 2024-01-19 US US18/418,050 patent/US20240408189A1/en active Pending

Also Published As

Publication number	Publication date
US10780157B2 (en)	2020-09-22
US20210220465A1 (en)	2021-07-22
US11633468B2 (en)	2023-04-25
US11911456B2 (en)	2024-02-27
WO2013057191A1 (en)	2013-04-25
US20210023196A1 (en)	2021-01-28
US10258685B2 (en)	2019-04-16
US20170281748A1 (en)	2017-10-05
US20140255425A1 (en)	2014-09-11
US10675344B2 (en)	2020-06-09
US20190209675A1 (en)	2019-07-11
EP2768527B1 (en)	2017-08-09
US20200000908A1 (en)	2020-01-02
DK2768527T3 (da)	2017-11-06
ES2643696T3 (es)	2017-11-23
US20240408189A1 (en)	2024-12-12
EP2583688A1 (en)	2013-04-24
EP2583688A9 (en)	2013-10-09
EP2768527A1 (en)	2014-08-27

Publication	Publication Date	Title
ZA201403795B (en)	2016-01-27	Formulations for the treatment of diabetes
GB201112931D0 (en)	2011-09-14	Metail 3
AP2014007399A0 (en)	2014-01-31	Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
EP2774917A4 (en)	2015-05-06	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
IL234867A0 (en)	2014-12-31	Prevention and treatment of disease related to the tooth bearing
SG11201501289TA (en)	2015-04-29	Preparation for preventing or treating type i diabetes
IL238331A0 (en)	2015-06-30	A method for treating type I and type II diabetes
ZA201308117B (en)	2014-12-23	Avian-based treatment
IL228589A0 (en)	2013-12-31	Medical Care
ZA201404542B (en)	2015-09-30	Fabric treatment composition
DK2768527T3 (da)	2017-11-06	Multi-cbv-vaccine til at forebygge eller behandle type 1-diabetes
GB201102283D0 (en)	2011-03-23	Treatment
GB201112345D0 (en)	2011-08-31	Insecticidal treatment
GB201102263D0 (en)	2011-03-23	Treatment
GB201102271D0 (en)	2011-03-23	Treatment
GB201102265D0 (en)	2011-03-23	Treatment
GB201102268D0 (en)	2011-03-23	Treatment
GB201102282D0 (en)	2011-03-23	Treatment
GB201109119D0 (en)	2011-07-13	Treatment
GB201102269D0 (en)	2011-03-23	Treatment
GB201102274D0 (en)	2011-03-23	Treatment
GB201102270D0 (en)	2011-03-23	Treatment
GB201102284D0 (en)	2011-03-23	Treatment
GB201102266D0 (en)	2011-03-23	Treatment
GB201102272D0 (en)	2011-03-23	Treatment